About Xeroderma Pigmentosum

Xeroderma Pigmentosum (XP) is a rare genetic disorder that affects the body’s ability to repair damage caused by ultraviolet (UV) light. Because of this defect, individuals with XP are extremely sensitive to sunlight and other sources of ultraviolet radiation.

The condition most commonly affects areas exposed to UV light, including the:

• Skin

• Eyes

Without strict protection from UV exposure, individuals with XP face a significantly increased risk of severe skin damage, eye damage, and skin cancer.

There is currently no cure for Xeroderma Pigmentosum. Treatment primarily focuses on avoiding ultraviolet exposure and managing complications caused by the condition.

Causes of Xeroderma Pigmentosum

XP is an inherited genetic disorder caused by mutations affecting the body’s ability to repair damaged DNA after ultraviolet exposure.

Even small amounts of UV exposure can cause significant harm to individuals with XP.

Sources of UV exposure may include:

• Sunlight

• Sunlight through windows

• Fluorescent lighting

• Certain artificial light sources

Because of this, many individuals with XP must take extensive protective measures throughout daily life.

Symptoms of Xeroderma Pigmentosum

Symptoms of XP may vary depending on the severity of the condition and the amount of UV exposure.

Common skin-related symptoms may include:

• Blistering skin

• Severe sunburns

• Skin inflammation

• Development of freckles at an early age

• Skin discoloration

• Spider veins

• Fatigue

• Weakness

• Increased risk of skin cancer

Even brief sun exposure may result in severe skin damage.

Eye-Related Symptoms

XP also commonly affects the eyes, which can become extremely sensitive to ultraviolet light.

Eye-related symptoms may include:

• Bloodshot eyes

• Eye irritation

• Clouding of the cornea

• Loss of eyelashes

• Abnormal eyelid curvature

• Eye cancer

• Vision loss

Without proper protection, UV exposure can lead to progressive eye damage over time.

Qualifying for Social Security Disability with Xeroderma Pigmentosum

The Social Security Administration (SSA) evaluates Xeroderma Pigmentosum under Listing 8.07 – Genetic Photosensitivity Disorders within the skin disorders section of the Blue Book.

Because XP is considered a severe and rare condition, individuals with documented diagnoses often qualify for disability benefits.

Listing 8.07 – Genetic Photosensitivity Disorders

An applicant may qualify if they have:

• Xeroderma Pigmentosum as described under Section 8.00E of the Blue Book

Required Medical Documentation

The SSA requires medical documentation from an acceptable medical source confirming the diagnosis of XP.

Helpful evidence may include:

• Genetic laboratory testing

• Chromosomal analysis

• Dermatology records

• Ophthalmology records

• Skin biopsy results

• Documentation of UV sensitivity and related complications

The SSA generally requires laboratory findings showing genetic abnormalities consistent with Xeroderma Pigmentosum.

Compassionate Allowance Program

Xeroderma Pigmentosum is included on the Social Security Administration’s Compassionate Allowances list.

The Compassionate Allowances program was created to quickly identify severe medical conditions that clearly meet disability standards.

Claims involving Compassionate Allowance conditions are typically processed faster so applicants can receive benefits more quickly.

Functional Limitations Caused by XP

XP may significantly interfere with daily activities and the ability to work due to the need for constant UV protection and ongoing medical complications.

Functional limitations may include:

• Inability to tolerate sunlight or standard lighting conditions

• Increased risk of skin cancer

• Vision problems

• Chronic skin damage

• Fatigue and weakness

• Need for strict environmental control

These limitations can make many work environments unsafe or impractical for individuals with XP.

Medical Evidence for an XP Disability Claim

Strong medical evidence is important when applying for disability benefits with Xeroderma Pigmentosum. Helpful documentation may include:

• Genetic testing results

• Dermatology evaluations

• Eye examinations

• Cancer treatment records

• Physician statements regarding functional limitations

• Documentation of UV sensitivity and required protective measures

The SSA evaluates how the condition affects the individual’s safety, vision, daily functioning, and ability to maintain consistent employment.